SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Teva Pharm Seen Growing Further in 2027 Despite IRA Impact on Austedo

The report says Teva Pharm is expected to grow further in 2027 despite the U.S. IRA’s impact on Austedo.

Related stories